info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Meralgia Paresthetica Market Share

ID: MRFR//3870-HCR | 105 Pages | Author: Rahul Gotadki| November 2024

The Meralgia Paresthetica market, centered on a nerve disorder causing thigh pain and tingling, requires strategic market positioning to address the unique challenges of this relatively uncommon condition. In this specialized market, effective strategies are crucial for companies providing diagnostic and therapeutic solutions for individuals suffering from Meralgia Paresthetica.
The first step in effective market positioning is an elaborate evaluation of the demographics targeted by Meralgia Paresthetica. Symptoms associated with this nerve disorder showage, occupation and lifestyle therefore companies need to understand these factors in order to target them based on specific needs by those affected.
To remain at the vanguard in Meralgia Paresthetica market one also has to keep innovating new diagnostic technologies. Companies should fund in the research and development to advance visual mechanisms on fundamental imaging methods and diagnostic tools that assure precise prompt identification of Meralgia Paresthetica, allowing immediate intervention.
Market share positioning requires building effective collaborations with neurologists and pain management specialists. Partnership building can result in more recommendations to improve the company’s diagnostic tools and therapeutic interventions; this builds trust among HCP and patients suffering from MP.
Simultaneously, market penetration is directly related to educational initiatives aimed at healthcare professionals. Companies should conduct seminars, workshops and training sessions to improve the knowledge and competence of neurologists or specialists concerning Meralgia Paresthetica’s diagnosis/ treatment. This would brand the company as a leader in Neurology education.
Market growth depends on the information campaign directed to patients about Meralgia Paresthetica and treatment possibilities. Firms should pay attention to setting up various adversities and support on the field of patient training educating about options for pathology in detail, potential triggers as well as variety therapeutic practices available which modal strategies allow people minimize their symptoms.
In the market of Meralgia Paresthetica one has to adjust marketing plans in such a way that this information may be delivered and understood not just by doctors but also by patients. Usage of many channels, such as medical gatherings and digitized networks; educational materials would therefore be able adjust the advantages recommended by a few edge methods measurable therapeutic contribution set this company offer in modern specialized market.
Post-treatment patient support is an essential requirement that necessarily affects the level of patients’ satisfaction and consequent longstanding results. Companies should offer resources, counseling services and information pamphlets to help people cope with the constant presence of Meralgia Paresthetica as well as ensure complete individual wellbeing.

Staying informed about industry trends and monitoring the competitive landscape is crucial for adapting market positioning strategies. Regular assessments of competitors' activities, emerging technologies, and evolving research in Meralgia Paresthetica enable companies to make informed decisions, stay competitive, and maintain a leading position in this dynamic and specialized healthcare market.

Covered Aspects:

Report Attribute/Metric Details
Base Year For Estimation   2021
Forecast Period   2023-2032
Growth Rate   3.3% (2023-2032)

Meralgia Paresthetica Market Overview


The Meralgia Paresthetica Market is expected to reach USD 1.7 Billion by 2032 at 3.3% CAGR during the forecast period 2023-2032. Meralgia paresthetica is a condition characterized by tingling, numbness and burning pain in outer thigh. The major cause of meralgia paresthetica is compression of the nerve that supplies sensation to the skin surface of the thigh. 


Meralgia Paresthetica Market


The meralgia paresthetica market growth is majorly attributed to the increasing prevalence of obesity, rising funding, and healthcare insurance coverage. Moreover, common causes of this compression includes any condition that increases pressure on the groin such as tight clothing i.e. belts, corsets and tight pants, obesity or weight gain, wearing a heavy tool belt, pregnancy, scar tissue near the inguinal ligament due to injury or any previous surgery. Furthermore, nerve injury, which due to diabetes or seat belt injury after an accident (by motor vehicle), can also cause meralgia paresthetica.


As per the National Diabetes Statistics Report suggested by the Centers for Disease Control and Prevention, it is found that 9.4% of the U.S. population i.e. 30.3 million people had diabetes in 2015. The rising prevalence of diabetes in low and middle-income countries appears to be fuelled by nutrition transition, rapid urbanization, and increasingly sedentary lifestyles, suggested by a study published in the journal Pharmacoeconomics in 2015. 


Furthermore, globalization in healthcare has increased the market growth. Established market players in the developed countries leads the globalization by pushing new products and services into the developing countries and emerging economies. According to the World Health Organization estimates, head injuries are responsible for 4.5%-11% of all injuries in the world including low or high income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.


On the other hand, availability of expensive treatment may hamper the meralgia paresthetica market growth during the forecast period.


Intended Audience



  • Medical Devices Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities


Figure: Global Meralgia Paresthetica Market, By Region Market Share, 2016 (%) Meralgia Paresthetica Market

Sources: Annual reports, Press release, White paper, Company presentation


Meralgia Paresthetica Market Segmentations


The Meralgia Paresthetica Market is segmented on the basis of types, by treatment, and by end user.


On the basis of diagnosis, meralgia paresthetica market is segmented into imaging techniques, electromyography, nerve conduction study, nerve blockade. Imaging techniques are further segmented as X-ray radiography, magnetic resonance imaging, medical ultrasonography or ultrasound, and others.


Based on the treatment, meralgia paresthetica market is segmented into medication, surgery, and others. Medication is further segmented into corticosteroid injections, tricyclic antidepressants, and anti-seizure. Anti-seizure is further segmented into gabapentin (gralise, neurontin), phenytoin (Dilantin) or pregabalin (lyrica) and others.


On the basis of end user, meralgia paresthetica market is segmented into hospitals & clinics, research laboratories, and others.


Meralgia Paresthetica Market Key Players


Some of key the players in the meralgia paresthetica market are: 



  • LivaNova PLC (U.K)

  • EnteroMedics Inc. (U.S.)

  • ElectroCore Medical LLC (U.S.)

  • Boston Scientific Corporation (U.S.)

  • Cyberonics, Inc. (U.S.)

  • NeuroMetrix, Inc.(U.S.)

  • ImThera Medical (U.S.)

  • Inspire Medical Systems, Inc.(U.S.) 


Research Methodology Meralgia Paresthetica Market 2018 Sources: Annual reports, Press release, White paper, and Company presentation


Meralgia Paresthetica Market Regional Analysis


The Americas dominate the meralgia paresthetica market owing to well-developed technology, increasing patient with obesity, high healthcare spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.


Europe holds the second position in the meralgia paresthetica market owing to the government support for research & development and availability of funds for research. Moreover, this is expected to continue to drive the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain.    


Asia Pacific is the fastest growing meralgia paresthetica market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods for chronic diseases in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead to the use of advanced equipment, which, in turn, will increase the market growth of meralgia paresthetica in the region.   


On the other hand, in the Middle East and Africa, obesity and diabetes have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.